Department of Genetics, The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 31096, Israel.
Institute for Ophthalmic Research, Centre for Ophthalmology, University Clinics Tuebingen, Germany.
Exp Eye Res. 2014 Aug;125:217-25. doi: 10.1016/j.exer.2014.06.017. Epub 2014 Jun 30.
Retinitis pigmentosa (RP) is the most common form of hereditary retinal degeneration. Mutations of the PRCD gene are associated with RP in both dogs and humans. To date, four distinct PRCD mutations have been reported worldwide. Here we report the clinical phenotype of another patient with PRCD mutations, carrying the known p.R18X mutation and a novel missense mutation, p.P25T. This mutation affects a highly conserved amino acid, is predicted to be damaging by several prediction tools, and was not found in the public databases or in 115 ethnically-matched control individuals. The phenotype of this patient resembles that of previously reported patients with PRCD mutations, including bull's eye maculopathy, which appears to be a hallmark of the PRCD-induced phenotype. PRCD encodes for a 54 amino acids long protein with unknown function. The first 20 amino acids appear to encode for a signal peptide (SP), suggesting that PRCD is a secreted protein. To study PRCD secretion, C-terminally myc-tagged PRCD was expressed in cultured cells. Cells and conditioned media were analyzed by Western blot. PRCD was found in both cell extracts and media. However, a truncated PRCD protein lacking the first 20 amino acids was present only in cell extracts and not in media, confirming that PRCD extracellular secretion is mediated by its N-terminal SP. To characterize the secretory pathway of PRCD, various pharmacological agents which interfere with transport of proteins through the ER and Golgi to the plasma membrane were used. PRCD secretion was significantly inhibited by all tested pharmacological agents, confirming that it is secreted through the classic ER/Golgi-dependent secretory pathway. We tested the effect of two mutations on the PRCD protein, and found that p.C2Y, but not p.P25T, affects protein stability, and that neither mutation affects secretion. Our data suggest that PRCD functions as a secreted protein. These findings shed a new light on PRCD function and the etiology of RP.
色素性视网膜炎(RP)是最常见的遗传性视网膜变性形式。PRCD 基因突变与犬和人类的 RP 有关。迄今为止,全球已报道了四种不同的 PRCD 突变。在这里,我们报告了另一位 PRCD 基因突变患者的临床表型,该患者携带已知的 p.R18X 突变和一种新的错义突变 p.P25T。该突变影响高度保守的氨基酸,被几种预测工具预测为有害,并且未在公共数据库或 115 名种族匹配的对照个体中发现。该患者的表型与先前报道的 PRCD 突变患者相似,包括牛眼黄斑病变,这似乎是 PRCD 诱导表型的标志。PRCD 编码一个未知功能的 54 个氨基酸长的蛋白质。前 20 个氨基酸似乎编码信号肽(SP),表明 PRCD 是一种分泌蛋白。为了研究 PRCD 的分泌,在培养的细胞中表达了 C 端 myc 标记的 PRCD。通过 Western blot 分析细胞和条件培养基。PRCD 存在于细胞提取物和培养基中。然而,仅在细胞提取物中而不在培养基中存在缺乏前 20 个氨基酸的截断 PRCD 蛋白,证实 PRCD 细胞外分泌是通过其 N 端 SP 介导的。为了表征 PRCD 的分泌途径,使用了各种干扰蛋白质通过内质网和高尔基体运输到质膜的药理学试剂。所有测试的药理学试剂均显著抑制 PRCD 分泌,证实其通过经典的内质网/高尔基体依赖性分泌途径分泌。我们测试了两种突变对 PRCD 蛋白的影响,发现 p.C2Y,但不是 p.P25T,影响蛋白稳定性,并且两种突变都不影响分泌。我们的数据表明 PRCD 作为一种分泌蛋白发挥作用。这些发现为 PRCD 功能和 RP 的病因学提供了新的线索。